Ovintiv (NYSE:OVV – Free Report) had its target price increased by The Goldman Sachs Group from $47.00 to $56.00 in a report published on Tuesday morning, Benzinga reports. They currently have a neutral rating on the stock. A number of other brokerages have also recently issued reports on OVV. Royal Bank of Canada upped their […]